Browse the corpus

REFERENCES Hamdy N, Kanis JA, Beneton MN, et al, “Effect of Alfacalcidol on Natural Course of Renal Bone Disease in Mild to Moderate Renal Failure,” BMJ , 1995, 310(6976):358-63. [PubMed 7677827 ] "K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease, Guideline 1. Evaluation of Calcium and Phosphorus Metabolism." Available at file://www.kidney.org/professionals/KDOQI/guidelines_bone/Guide1.htm "K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease, Guideline 3. Evaluation of Serum Phosphorus Levels." Available at file://www.kidney.org/professionals/KDOQI/guidelines_bone/Guide3.htm “K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease, Guideline 6. Serum Calcium and Calcium-Phosphorus Product.” Available at file://www.kidney.org/professionals/KDOQI/guidelines_bone/Guide6.htm [PubMed 14520607 ] "K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease, Guideline 8A. Active Vitamin D Therapy in Patients With Stages 3 and 4 CKD." Available at file://www.kidney.org/professionals/KDOQI/guidelines_bone/Guide8A.htm "K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease, Guideline 8B. Vitamin D Therapy in Patients on Dialysis (CKD Stage 5)." Available at file://www.kidney.org/professionals/KDOQI/guidelines_bone/Guide8B.htm "K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification, Part 4. Definition and Classification of Stages of Chronic Kidney Disease." Available at file://www.kidney.org/professionals/KDOQI/guidelines_ckd/p4_class.htm Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, "KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)," Kidney Int Suppl , 2009, 76(S113):1-130. [PubMed 19644521 ] Levin A, Hemmelgarn B, Culleton B, et al, “Canadian Guidelines for the Management of Chronic Kidney Disease,” CMAJ , 2008, 179(11):1154-62. [PubMed 19015566 ] Tarrass F, Yazidi A, Sif H, et al, “A Randomized Trial of Intermittent Versus Continuous Oral Alfacalcidiol Treatment of Hyperparathyroidism in End-Stage Renal Disease,” Clin Nephrol , 2006, 65(6):415-8. [PubMed 16792136 ] Topic 16467 Version 16.0

Levin A, Hemmelgarn B, Culleton B, et al, “Canadian Guidelines for the Management of Chronic Kidney Disease,” CMAJ , 2008, 179(11):1154-62. [PubMed 19015566 ] Tarrass F, Yazidi A, Sif H, et al, “A Randomized Trial of Intermittent Versus Continuous Oral Alfacalcidiol Treatment of Hyperparathyroidism in End-Stage Renal Disease,” Clin Nephrol , 2006, 65(6):415-8. [PubMed 16792136 ] Topic 16467 Version 16.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1004-61.234.146.186-7727F3B860-S244013.14]